Key points are not available for this paper at this time.
BP elevations following esketamine dosing are generally transient, asymptomatic, and not associated with serious cardiovascular safety sequalae. Further evaluation of long-term cardiovascular outcomes is warranted.
Doherty et al. (Wed,) studied this question.